Author Archive: BIOtechNOW Editor

My Regeneration

brain-scan

What can today’s generation hope for from regenerative medicine? It’s a frontier for business, the medical profession and society. Regenerative medicine aims to shift the focus from palliative care to the development of treatments that address diabetes, Parkinson’s disease, stroke and heart disease. The hope is that we’ll live longer, healthier lives and have greater independence in old age, thereby reducing the burden on healthcare systems. Given global population demographics, this is essential: according to the World Health Organisation by Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , ,

Can GMO’s can be a win-win for the U.S. and China?

matt O'mara115x76

Much has been written in the media recently about China’s rejection of shipments containing varieties of unapproved genetically modified corn. Trade disruption such as this is unnecessary and costly because the product in question has been approved for use in food, feed and for cultivation in several countries, including Argentina, Brazil, the European Union and the United States. This exposes a significant vulnerability in global commodity trade, as most countries maintain a zero tolerance policy Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Biodiesel Production from Sugarcane

shutterstock_27291016

A multi-institutional team led by plant biology professor Stephen P. Long from the University of Illinois reports that it can increase sugarcane’s geographic range, boost its photosynthetic rate by 30 percent and turn it into an oil-producing crop for biodiesel production. These are the first steps in a bigger initiative that will turn sugarcane and sorghum – two of the most productive crop plants known – into even more productive, oil-generating plants. The team presented Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Ensuring the Safety and Commercial Success of Biosimilars in the United States

attendees

The forthcoming arrival of biosimilars into the U.S has spurred debate over the approaches that the FDA and industry should take to ensure patient safety while promoting market competition and continued biomedical innovation. During a presentation Tuesday at the 2014 BIO International Convention, participants at this Super Session focused on the need for prescribing physicians and providers to closely partners with one another to ensure that safety and efficacy are the priorities in the debate Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Fighting Prostate Cancer with Immunotherapy

shutterstock_27291016

Advaxis and UC San Francisco join forces to develop and test a range of novel constructs Prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. According to the American Cancer Society, around 230,000 new cases of prostate cancer are diagnosed and 30,000 men die from the disease each year. Cancer immunotherapy offers one promising approach to combating the disease. The University of California, San Francisco, (UCSF) and biotechnology Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,